During the past decade, CH Mont de Marsan conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 2 clinical trials were completed, i.e. on average, 4.2% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 2 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH Mont de Marsan" #1 sponsor was "Intergroupe Francophone de Cancerologie Thoracique" with 11 trials, followed by "Federation Francophone de Cancerologie Digestive" with 10 trials sponsored, "University Hospital, Bordeaux" with 9 trials sponsored, "ARCAGY/ GINECO GROUP" with 8 trials sponsored and "GERCOR - Multidisciplinary Oncology Cooperative Group" with 8 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH Mont de Marsan" #1 collaborator was "Hoffmann-La Roche" with 3 trials as a collaborator, "UNICANCER" with 3 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 2 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "CH Mont de Marsan" are "Breast Cancer" (8 trials), "Ovarian Cancer" (6 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Colorectal Cancer" (4 trials) and "Metastatic Colorectal Cancer" (4 trials). Many other conditions were trialed in "CH Mont de Marsan" in a lesser frequency.

Most popular intervention types in "CH Mont de Marsan" are "Drug" (56 trials), "Other" (13 trials), "Procedure" (10 trials), "Biological" (5 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (6 trials), "Placebo" (5 trials), "gemcitabine hydrochloride" (5 trials), "fluorouracil" (4 trials) and "Bevacizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "CH Mont de Marsan" are 63 trials for "All" genders, 21 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "CH Mont de Marsan". 1 are not yet recruiting, 14 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in CH Mont de Marsan, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in CH Mont de Marsan, 2 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".

CH Mont de Marsan has several departments that took part in Clinical trials: "Hopital Layne; Medecine Ambulatoire" - 6 trials